Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study Investigating the Efficacy of Switching From Metformin Monotherapy to a Dual Therapy of Metformin and Repaglinide on Glycaemic Control in Type 2 Diabetes

NCT00709917 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00709917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00709917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study Investigating the Efficacy of Switching From Metformin Monotherapy to a Dual Therapy of Metformin and Repaglinide on Glycaemic Control in Type 2 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
March 31, 2007
Completion date
January 31, 2008
Enrollment
2,171 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2